Crispr Cas9 Technology - Genetic Mutations

Relevant Publications

CRISPR-Mediated Construction of Gene-Knockout Mice for Investigating Antiviral Innate Immunity.

Issue Release: 2025

Zebrafish as a Model for Investigating Antiviral Innate Immunity.

Issue Release: 2025

Delivery of CRISPR/Cas9 system by AAV as vectors for gene therapy.

Issue Release: 2024

CRISPR/Cas9-mediated genome editing of the thymidine kinase gene in a clinical HSV-1 isolate identifies F289S as novel acyclovir-resistant mutation.

Issue Release: 2024

CRISPR/Cas9-based engineered Escherichia coli biosensor for sensitive and specific detection of Cd(II) in drinking water.

Issue Release: 2024

miR-504 knockout regulates tumor cell proliferation and immune cell infiltration to accelerate oral cancer development.

Issue Release: 2024

AKR1C4 regulates the sensitivity of colorectal cancer cells to chemotherapy through ferroptosis modulation.

Issue Release: 2024

Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.

Issue Release: 2024

Investigating the potential of X chromosome shredding for mouse genetic biocontrol.

Issue Release: 2024

Unraveling the Impact of the PROCA1 Mutation in Male Infertility: Incorporating Whole Exome Sequencing in Teratozoospermia Patients and Analyzing Proca1 Knockout Mice.

Issue Release: 2024

Differential requirement of the transcription factor HOXC13 for the stable maintenance of human papillomavirus genome among high-risk genotypes.

Issue Release: 2024

CRISPR-mediated editing of β-lactoglobulin (BLG) gene in buffalo.

Issue Release: 2024

Loss of ADAR1 induces ferroptosis of breast cancer cells.

Issue Release: 2024

Long-Term Protection against Virulent Newcastle Disease Virus (NDV) in Chickens Immunized with a Single Dose of Recombinant Turkey Herpesvirus Expressing NDV F Protein.

Issue Release: 2024

Induced Pluripotent Stem Cells and CRISPR-Cas9 Innovations for Treating Alpha-1 Antitrypsin Deficiency and Glycogen Storage Diseases.

Issue Release: 2024

MicroRNA-384 radiosensitizes human non-small cell lung cancer by impairing DNA damage response and repair signaling, which is inhibited by NF-κB.

Issue Release: 2024

Dysfunction of Complementarity Determining Region 1 Encoded by T Cell Receptor Beta Variable Gene Is Potentially Associated with African Swine Fever Virus Infection in Pigs.

Issue Release: 2024

Knockout of the Chlorophyll a Oxygenase Gene Reduces Chilling Tolerance in Rice Seedlings.

Issue Release: 2024

Advances in and Perspectives on Transgenic Technology and CRISPR-Cas9 Gene Editing in Broccoli.

Issue Release: 2024

Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy.

Issue Release: 2024

How Do These Mutagens Affect DNA?

What is the Future of Genetic Research?

Are All Nucleotide Mutations Harmful?

What are the Treatment Options for Cystic Fibrosis?

Where Do Neutral Mutations Typically Occur?

How Can Pharmacogenomics Be Integrated into Clinical Practice?

What Types of Radiation Are Most Harmful?

What Makes a Mutation Harmful?

What is Karyotyping?

How are Results Validated?

Partnered Content Networks

Relevant Topics